The Korean journal of internal medicine

The Korean Association of Internal Medicine (대한내과학회)
권호 표지
DOI QR코드

DOI QR Code

Validation of the Oxford Classification of IgA Nephropathy: A Single-Center Study in Korean Adults

  • Lee, Ho-Young (Department of Internal Medicine, Soonchunhyang University Hospital) ;
  • Yi, Sul-Hee (Department of Internal Medicine, Soonchunhyang University Hospital) ;
  • Seo, Mi-Seon (Department of Internal Medicine, Soonchunhyang University Hospital) ;
  • Hyun, Jin-Nam (Department of Internal Medicine, Soonchunhyang University Hospital) ;
  • Jeon, Jin-Seok (Department of Internal Medicine, Soonchunhyang University Hospital) ;
  • Noh, Hyun-Jin (Department of Internal Medicine, Soonchunhyang University Hospital) ;
  • Han, Dong-Cheol (Department of Internal Medicine, Soonchunhyang University Hospital) ;
  • Hwang, Seung-Duk (Department of Internal Medicine, Soonchunhyang University Bucheon Hospital) ;
  • Jin, So-Young (Department of Pathology, Soonchunhyang University Hospital) ;
  • Kwon, Soon-Hyo (Department of Internal Medicine, Soonchunhyang University Hospital)
  • Published : 2012.09.01
⟨ Previous Next ⟩

Abstract

Background/Aims: The recently published Oxford classification of IgA nephropathy (IgAN) proposed a split system for histological grading, based on prognostic pathological features. This new classification system must be validated in a variety of cohorts. We investigated whether these pathological features were applicable to an adult Korean population. Methods: In total, 69 adult Korean patients with IgAN were analyzed using the Oxford classification system at Soonchunhyang University Hospital, Seoul, Korea. All cases were categorized according to Lee's classification. Renal biopsies from all patients were scored by a pathologist who was blinded to the clinical data for pathological variables. Inclusion criteria were age greater than 18 years and at least 36 months of follow-up. We excluded cases with secondary IgAN, diabetic nephropathy combined other glomerulopathies, less than 36 months of follow-up, and those that progressed rapidly. Results: The median age of the patients was 34 years (range, 27 to 45). Mean arterial blood pressure was 97 ${\pm}$ 10 mmHg at the time of biopsy. The median follow-up period was 85 months (range, 60 to 114). Kaplan-Meier analysis showed significant prognostic predictions for M, E, and T lesions. A Cox proportional hazard regression analysis also revealed prognostic predictions for E and T lesions. Conclusions: Using the Oxford classification in IgAN, E, and T lesions predicted renal outcome in Korean adults after taking clinical variables into account.

Keywords

References

  1. Neelakantappa K, Gallo GR, Baldwin DS. Proteinuria in IgA nephropathy. Kidney Int 1988;33:716-721. https://doi.org/10.1038/ki.1988.57
  2. Alamartine E, Sabatier JC, Guerin C, Berliet JM, Berthoux F. Prognostic factors in mesangial IgA glomerulonephritis: an extensive study with univariate and multivariate analyses. Am J Kidney Dis 1991;18:12-19. https://doi.org/10.1016/S0272-6386(12)80284-8
  3. Walsh M, Sar A, Lee D, et al. Histopathologic features aid in predicting risk for progression of IgA nephropathy. Clin J Am Soc Nephrol 2010;5:425-430. https://doi.org/10.2215/CJN.06530909
  4. Coppo R. Pediatric IgA nephropathy: clinical and therapeutic perspectives. Semin Nephrol 2008;28:18-26. https://doi.org/10.1016/j.semnephrol.2007.10.003
  5. Coppo R, Gianoglio B, Porcellini MG, Maringhini S. Frequency of renal diseases and clinical indications for renal biopsy in children (report of the Italian National Registry of Renal Biopsies in Children): group of renal immunopathology of the Italian Society of Pediatric Nephrology and group of renal immunopathology of the Italian Society of Nephrology. Nephrol Dial Transplant 1998;13:293-297. https://doi.org/10.1093/oxfordjournals.ndt.a027821
  6. Haas M. Histologic subclassification of IgA nephropathy: a clinicopathologic study of 244 cases. Am J Kidney Dis 1997;29:829-842. https://doi.org/10.1016/S0272-6386(97)90456-X
  7. Ibels LS, Gyory AZ. IgA nephropathy: analysis of the natural history, important factors in the progression of renal disease, and a review of the literature. Medicine (Baltimore) 1994;73:79-102. https://doi.org/10.1097/00005792-199403000-00002
  8. Working Group of the International IgA Nephropathy Network and the Renal Pathology Society, Roberts IS, Cook HT, et al. The Oxford classification of IgA nephropathy: pathology definitions, correlations, and reproducibility. Kidney Int 2009;76:546-556. https://doi.org/10.1038/ki.2009.168
  9. Wakai K, Kawamura T, Endoh M, et al. A scoring system to predict renal outcome in IgA nephropathy: from a nationwide prospective study. Nephrol Dial Transplant 2006;21:2800-2808. https://doi.org/10.1093/ndt/gfl342
  10. Lee HS, Lee MS, Lee SM, et al. Histological grading of IgA nephropathy predicting renal outcome: revisiting H. S. Lee's glomerular grading system. Nephrol Dial Transplant 2005;20:342-348. https://doi.org/10.1093/ndt/gfh633
  11. Working Group of the International IgA Nephropathy Network and the Renal Pathology Society, Cattran DC, Coppo R, et al. The Oxford classification of IgA nephropathy: rationale, clinicopathological correlations, and classification. Kidney Int 2009;76:534-545. https://doi.org/10.1038/ki.2009.243
  12. Lee SM, Rao VM, Franklin WA, et al. IgA nephropathy: morphologic predictors of progressive renal disease. Hum Pathol 1982;13:314-322. https://doi.org/10.1016/S0046-8177(82)80221-9
  13. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999;130:461-470. https://doi.org/10.7326/0003-4819-130-6-199903160-00002
  14. Levey AS, Coresh J, Greene T, et al. Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med 2006;145:247-254. https://doi.org/10.7326/0003-4819-145-4-200608150-00004
  15. Herzenberg AM, Fogo AB, Reich HN, et al. Validation of the Oxford classification of IgA nephropathy. Kidney Int 2011;80:310-317. https://doi.org/10.1038/ki.2011.126
  16. Manno C, Strippoli GF, D'Altri C, Torres D, Rossini M, Schena FP. A novel simpler histological classification for renal survival in IgA nephropathy: a retrospective study. Am J Kidney Dis 2007;49:763-775. https://doi.org/10.1053/j.ajkd.2007.03.013
  17. Kobayashi Y, Tateno S, Hiki Y, Shigematsu H. IgA nephropathy: prognostic significance of proteinuria and histological alterations. Nephron 1983;34:146-153. https://doi.org/10.1159/000183000
  18. Wyatt RJ, Emancipator SN, Kon V, et al. IgA nephropathy databank: development of a system for management of renal biopsy acquired data. Am J Kidney Dis 1997;29:817-828. https://doi.org/10.1016/S0272-6386(97)90455-8
  19. Haas M, Rahman MH, Cohn RA, Fathallah-Shaykh S, Ansari A, Bartosh SM. IgA nephropathy in children and adults: comparison of histologic features and clinical outcomes. Nephrol Dial Transplant 2008;23:2537-2545. https://doi.org/10.1093/ndt/gfn014
  20. Kang SH, Choi SR, Park HS, et al. The Oxford classification as a predictor of prognosis in patients with IgA nephropathy. Nephrol Dial Transplant 2012;27:252-258. https://doi.org/10.1093/ndt/gfr295
  21. Working Group of the International IgA Nephropathy Network and the Renal Pathology Society, Coppo R, Troyanov S, et al. The Oxford IgA nephropathy clinicopathological classification is valid for children as well as adults. Kidney Int 2010;77:921-927. https://doi.org/10.1038/ki.2010.43

Cited by

  1. Validation of the Oxford classification of IgA nephropathy for pediatric patients from China vol.13, pp.None, 2012, https://doi.org/10.1186/1471-2369-13-158
  2. Validation Study of the Oxford Classification for IgA Nephropathy in Korean Adults vol.27, pp.3, 2012, https://doi.org/10.3904/kjim.2012.27.3.275
  3. Effect of treatment on urinary kidney injury molecule-1 in IgA nephropathy vol.14, pp.None, 2012, https://doi.org/10.1186/1471-2369-14-139
  4. Primary glomerulonephritis: A review of important recent discoveries vol.32, pp.3, 2012, https://doi.org/10.1016/j.krcp.2013.06.004
  5. Evaluation of the Oxford Classification of IgA Nephropathy: A Systematic Review and Meta-analysis vol.62, pp.5, 2012, https://doi.org/10.1053/j.ajkd.2013.04.021
  6. Urinary Prognostic Biomarkers and Classification of IgA Nephropathy by High Resolution Mass Spectrometry Coupled with Liquid Chromatography vol.8, pp.12, 2012, https://doi.org/10.1371/journal.pone.0080830
  7. N‐acetylgalactosamine exposure of serum IgA1 was associated with glomerulosclerosis and tubular atrophy/interstitial fibrosis of IgA nephropathy patients vol.19, pp.1, 2012, https://doi.org/10.1111/nep.12169
  8. Histologic classification of glomerular diseases: clinicopathologic correlations, limitations exposed by validation studies, and suggestions for modification vol.85, pp.4, 2014, https://doi.org/10.1038/ki.2013.375
  9. Pathology of IgA nephropathy vol.10, pp.8, 2014, https://doi.org/10.1038/nrneph.2014.92
  10. The Molecular Phenotype of Endocapillary Proliferation: Novel Therapeutic Targets for IgA Nephropathy vol.9, pp.8, 2012, https://doi.org/10.1371/journal.pone.0103413
  11. Validation of the Oxford classification of IgA nephropathy in cohorts with different presentations and treatments vol.86, pp.4, 2012, https://doi.org/10.1038/ki.2014.63
  12. Extracapillary proliferation in IgA nephropathy; recent findings and new ideas vol.4, pp.1, 2015, https://doi.org/10.12860/jnp.2015.01
  13. Pathology and Renal Outcome of IgA Nephropathy vol.88, pp.4, 2015, https://doi.org/10.3904/kjm.2015.88.4.397
  14. Distribution of Streptococcus mutans strains with collagen-binding proteins in the oral cavity of IgA nephropathy patients vol.19, pp.5, 2015, https://doi.org/10.1007/s10157-014-1072-0
  15. New developments in the genetics, pathogenesis, and therapy of IgA nephropathy vol.88, pp.5, 2012, https://doi.org/10.1038/ki.2015.252
  16. Extracapillary proliferation and arteriolar hyalinosis are associated with long-term kidney survival in IgA nephropathy vol.20, pp.4, 2016, https://doi.org/10.1007/s10157-015-1185-0
  17. IgA nephropathy clinicopathologic study following the Oxford classification: Progression peculiarities and gender-related differences vol.52, pp.6, 2012, https://doi.org/10.1016/j.medici.2016.11.003
  18. Glomerular IgG deposition predicts renal outcome in patients with IgA nephropathy vol.29, pp.7, 2012, https://doi.org/10.1038/modpathol.2016.77
  19. Update on immunoglobulin a nephropathy. Part II: Clinical, diagnostic and therapeutical aspects vol.5, pp.1, 2012, https://doi.org/10.5527/wjn.v5.i1.6
  20. Why, when and how should immunosuppressive therapy considered in patients with immunoglobulin A nephropathy? vol.186, pp.2, 2012, https://doi.org/10.1111/cei.12823
  21. Immunoglobulin a nephropathy: Pathological markers of renal survival in paediatric patients vol.21, pp.12, 2012, https://doi.org/10.1111/nep.12850
  22. Reproducibility for pathological prognostic parameters of the Oxford classification of IgA nephropathy: a Japanese cohort study of the Ministry of Health, Labor and Welfare vol.21, pp.1, 2012, https://doi.org/10.1007/s10157-016-1258-8
  23. The Japanese Histologic Classification and T-score in the Oxford Classification system could predict renal outcome in Japanese IgA nephropathy patients vol.21, pp.6, 2012, https://doi.org/10.1007/s10157-017-1393-x
  24. Oxford Classification of IgA nephropathy 2016: an update from the IgA Nephropathy Classification Working Group vol.91, pp.5, 2017, https://doi.org/10.1016/j.kint.2017.02.003
  25. IgA nephropathy: an update vol.26, pp.3, 2012, https://doi.org/10.1097/mnh.0000000000000312
  26. IgA Nephropathy in Salvador, Brazil. Clinical and laboratory presentation at diagnosis vol.40, pp.3, 2012, https://doi.org/10.1590/2175-8239-jbn-3851
  27. Renal outcomes of STOP-IgAN trial patients in relation to baseline histology (MEST-C scores) vol.19, pp.1, 2012, https://doi.org/10.1186/s12882-018-1128-6
  28. Immunoglobulin A Nephropathy and Immunoglobulin A Vasculitis vol.66, pp.1, 2012, https://doi.org/10.1016/j.pcl.2018.08.008
  29. Has The Time Arrived to Refine The Indications of Immunosuppressive Therapy and Prognosis in IgA Nephropathy? vol.8, pp.10, 2012, https://doi.org/10.3390/jcm8101584
  30. Graft failure of IgA nephropathy in renal allografts following living donor transplantation: predictive factor analysis of 102 biopsies vol.20, pp.1, 2012, https://doi.org/10.1186/s12882-019-1628-z
  31. Long-term renal survival and undetected risk factors of IgA nephropathy in Chinese children-a retrospective 1243 cases analysis from single centre experience vol.33, pp.6, 2012, https://doi.org/10.1007/s40620-020-00767-4
  32. The Utility of Assessing CD68+ Glomerular Macrophages in Assessing Endocapillary Hypercellularity in IgA Nephropathy vol.31, pp.1, 2021, https://doi.org/10.4103/ijn.ijn_380_19
  33. The Association of the Oxford Classification Score with Longitudinal Estimated Glomerular Filtration Rate Decline in Patients with Immunoglobulin A Nephropathy: A Mixed-Method Study vol.14, pp.None, 2012, https://doi.org/10.2147/ijgm.s313333
  34. Validation of an international prediction model including the Oxford classification in Korean patients with IgA nephropathy vol.26, pp.7, 2012, https://doi.org/10.1111/nep.13865